Fancy Thomas

628 total citations
7 papers, 387 citations indexed

About

Fancy Thomas is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Fancy Thomas has authored 7 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Fancy Thomas's work include Alzheimer's disease research and treatments (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Fancy Thomas is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Fancy Thomas collaborates with scholars based in United States and Canada. Fancy Thomas's co-authors include Paul R. Lockman, Rajendar K. Mittapalli, Kunal S. Taskar, Vinay Rudraraju, Helen R. Thorsheim, Quentin R. Smith, Patricia S. Steeg, Diane Palmieri, Julie A. Gaasch and David D. Allen and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Pharmacology and Experimental Therapeutics and Chemical Science.

In The Last Decade

Fancy Thomas

6 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fancy Thomas United States	6	122	113	100	78	70	7	387
Anthony J. Veloso Canada	15	208 1.7×	197 1.7×	64 0.6×	36 0.5×	83 1.2×	19	502
Mary E. Huff United States	8	362 3.0×	190 1.7×	37 0.4×	42 0.5×	30 0.4×	8	578
Christophe Landry France	13	198 1.6×	45 0.4×	211 2.1×	57 0.7×	34 0.5×	21	627
Sergei Aleshkov United States	7	196 1.6×	204 1.8×	35 0.3×	37 0.5×	32 0.5×	8	377
Joanne M. Caine Australia	14	314 2.6×	258 2.3×	87 0.9×	34 0.4×	129 1.8×	22	599
Jacky Wong United States	5	237 1.9×	104 0.9×	273 2.7×	19 0.2×	28 0.4×	6	555
Alexandra I. Mot Australia	7	116 1.0×	154 1.4×	73 0.7×	9 0.1×	37 0.5×	8	417
Clare Duncan Australia	12	220 1.8×	102 0.9×	220 2.2×	21 0.3×	27 0.4×	16	663
Naomi Shishido Japan	11	136 1.1×	191 1.7×	75 0.8×	7 0.1×	65 0.9×	30	525
Shiori Tamamizu‐Kato United States	6	480 3.9×	385 3.4×	40 0.4×	123 1.6×	54 0.8×	6	760

Countries citing papers authored by Fancy Thomas

Since Specialization

Citations

This map shows the geographic impact of Fancy Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fancy Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fancy Thomas more than expected).

Fields of papers citing papers by Fancy Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fancy Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fancy Thomas. The network helps show where Fancy Thomas may publish in the future.

Co-authorship network of co-authors of Fancy Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Fancy Thomas. A scholar is included among the top collaborators of Fancy Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fancy Thomas. Fancy Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Scott, Lauren E., Maria A. Telpoukhovskaia, Cristina Rodríguez‐Rodríguez, et al.. (2010). N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy. Chemical Science. 2(4). 642–648. 62 indexed citations

2.

Thomas, Fancy, Kunal S. Taskar, Vinay Rudraraju, et al.. (2009). Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer. Pharmaceutical Research. 26(11). 2486–2494. 173 indexed citations

3.

Thomas, Fancy, et al.. (2009). In vivo interactions of magnetic nanoparticles with the blood–brain barrier. Journal of Magnetism and Magnetic Materials. 321(10). 1591–1593. 16 indexed citations

4.

Gabathuler, R., Michel Demeule, Anthony Régina, et al.. (2008). 117 POSTER ANG1005, Paclitaxel conjugated to the angiopep brain transport vector for the treatment of brain cancer: preclinical studies. European Journal of Cancer Supplements. 6(12). 38–39. 1 indexed citations

5.

Lockman, Paul R., Vamshi K. Manda, Werner J. Geldenhuys, et al.. (2007). Carrier-Mediated Transport of the Quaternary Ammonium Neuronal Nicotinic Receptor Antagonist N,N′-Dodecylbispicolinium Dibromide at the Blood-Brain Barrier. Journal of Pharmacology and Experimental Therapeutics. 324(1). 244–250. 21 indexed citations

6.

Schugar, Harvey J., David E. Green, Meryn L. Bowen, et al.. (2007). Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation. Angewandte Chemie International Edition. 46(10). 1716–1718. 100 indexed citations

7.

Schugar, Harvey J., David E. Green, Meryn L. Bowen, et al.. (2007). Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation. Angewandte Chemie. 119(10). 1746–1748. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact